- Home
- HFRO vs BWAY Comparison
HFRO vs BWAY Comparison
Compare HFRO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFRO
- BWAY
- Stock Information
- Founded
- HFRO 2000
- BWAY 2003
- Country
- HFRO United States
- BWAY Israel
- Employees
- HFRO N/A
- BWAY N/A
- Industry
- HFRO Finance/Investors Services
- BWAY Medical/Dental Instruments
- Sector
- HFRO Finance
- BWAY Health Care
- Exchange
- HFRO Nasdaq
- BWAY Nasdaq
- Market Cap
- HFRO 287.7M
- BWAY 245.2M
- IPO Year
- HFRO N/A
- BWAY 2019
- Fundamental
- Price
- HFRO $5.23
- BWAY $11.73
- Analyst Decision
- HFRO
- BWAY Strong Buy
- Analyst Count
- HFRO 0
- BWAY 2
- Target Price
- HFRO N/A
- BWAY $14.25
- AVG Volume (30 Days)
- HFRO 179.8K
- BWAY 52.2K
- Earning Date
- HFRO 01-01-0001
- BWAY 08-05-2025
- Dividend Yield
- HFRO 8.87%
- BWAY N/A
- EPS Growth
- HFRO N/A
- BWAY N/A
- EPS
- HFRO N/A
- BWAY 0.08
- Revenue
- HFRO N/A
- BWAY $43,457,000.00
- Revenue This Year
- HFRO N/A
- BWAY $351.53
- Revenue Next Year
- HFRO N/A
- BWAY $21.84
- P/E Ratio
- HFRO N/A
- BWAY $57.82
- Revenue Growth
- HFRO N/A
- BWAY 26.86
- 52 Week Low
- HFRO $4.24
- BWAY $5.98
- 52 Week High
- HFRO $6.45
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- HFRO 51.63
- BWAY 45.41
- Support Level
- HFRO $5.19
- BWAY $11.54
- Resistance Level
- HFRO $5.25
- BWAY $12.95
- Average True Range (ATR)
- HFRO 0.08
- BWAY 0.52
- MACD
- HFRO -0.01
- BWAY -0.17
- Stochastic Oscillator
- HFRO 69.64
- BWAY 10.70
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.